CML Horizons 2020 Virtual Conference Information
Almost 400 people from 87 countries all over the world registered for the 18th edition of the CML Horizons Conference which took place virtually from 6 to 8 November 2020.
The annual meeting of the global CML patient advocacy community is dedicated to the development of our members as patient advocates and this year we have spotlighted topics such as History of CML, Challenges with COVID-19 & Access, Living well with CML, Generics, Therapy-free remission, and Building alliances and partnerships.
Watch videos of all sessions on demand
CML Advocates Network regional project: CML LATAM
The Latin American - CML Advocates Network region is currently developing an amazing advocacy program with the aim of improving access to medicines, best treatment and monitoring test, for people living with chronic myeloid leukemia in the region.
CML Horizons 2020 Virtual - Call for Posters
Call for posters
This year your posters will be displayed virtually and within our conference platform. There will be a Poster Area where we will display an image of participants poster illustrating their CML patient advocacy activities, projects, and outcomes.
Call for submissions closed on 5th November. Thanks you very much for your participation!
Welcome, FUNDALMC from Venezuela!
We hereby proudly welcome a new member organisation in the CML Advocates Network:
FUNDALMC - Fundación para la Asistencia al Paciente con Leucemia Mieloide Crónica based in Venezuela.
World CML Day 2020: Today, together, more than ever. For a life without CML
Every 22nd September, the CML Advocates Network leads the World CML Day global awareness campaign. On this day, chronic myeloid leukemia (CML) patients across the globe come together to raise awareness about our needs to the general public, politicians, and medical professionals across the world.
Today, together, more than ever due to the COVID-19 pandemic, the CML patient advocates need to connect as a worldwide community through digital tools by developing online activities.
Two months ahead of 22nd September, today we launch the World CML Day campaign, encouraging CML patients and patient organisations, health care providers, collaborators and all CML friends to join the global movement under a powerful motto:
"Today, together, more than ever. For a life without CML"
EHA 2020 Congress: CML updates and tips to a virtual attendance
EHA25 VIRTUAL: 25th EHA Annual Congress: "Unfolding the future!”
Just a week left until the European Hematology Association's annual congress starts as a virtual meeting this year! We hope many patients of the hematology community and specifically CML patient advocates, will be attending this impressive meeting from June 11-21, 2020 that is going to be held online due to the COVID-19 global pandemic.
Facing new challenges to bring an online platform to attendees, EHA2020 is offering this year a program with new types of sessions and schedulings through "On-demand" and "Live sessions" such as plenary presentations, award lectures, the presidential symposium and Satellite Symposia and Updates-in-Hematology organized by pharmaceutical companies.
Read more to see what has been offered specifically for patient advocates, hematologists and other stakeholders at #EHA25Virtual this year:
Results of the TFR for CML patients' study published in Leukemia
Bern, Switzerland, 28th May 2020.
“The psychological well-being of CML patients should be a consideration of healthcare professionals and addressed at all stages of the treatment-free remission journey”
- CML Advocates Network, the global network connecting 125 CML patient organisations in 93 countries, has published a paper in the prestigious journal Leukemia, considered one of the leading journals in hematology and oncology.
- The study, the main author of which is Giora Sharf, himself a CML patient, has identified chronic myeloid leukemia (CML) patients’ unmet needs during the treatment-free remission (TFR) journey.
The results of the study published on the paper “Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs" indicate that there are points in the TFR journey where patients do not always get all the advice, information or support they want around psychological issues and tyrosine kinase inhibitors (TKIs) withdrawal.
Welcome, ARCRare from Romania and HEMA from Macedonia!
We hereby proudly welcome two new member organisations in the CML Advocates Network:
Asociația Română de Cancere Rare/ Romanian Rare Cancers Association based in Romania and
HEMA-Association for support of patients and caregivers of Hematology diseases based in Macedonia.
The CML Advocates Network now counts a total of 125 member organisations in 93 countries worldwide! See the list of CML groups in the Network on our world map.
CML and COVID-19: New Website section on cmladvocates.net
The CML Advocates Network is closely monitoring the current COVID-19 outbreak worldwide.
We are happy to announce the launch of a new website section to better inform the CML patient advocacy community on what is happening around Chronic Myeloid Leukemia and COVID-19 globally.
In this section, we will regularly publish breaking news, scientific information and other support resources which may be of interest.
Advance your knowledge on the CML and COVID-19 global situation with access to the following topics:
CML Horizons 2020 conference moves to November 2020
In light of the circumstances surrounding the global COVID-19 outbreak, the CML Advocates Network Steering Committee met via video-conference on March 19 to decide on the future of our annual CML Horizons conference which was due to take place in San José, Costa Rica from May 1-3.
Given the health risks posed to patients as well as the current travel restrictions for which there is no firm indication as to how long they may continue, the Steering Committee has decided to cancel the Costa-Rica CML Horizons conference and to re-schedule the event, circumstances permitting, in Europe in November 2020.
Even though it has been a difficult decision, the health of conference delegates remains our priority. We will continue to closely monitor the global situation and incorporate WHO recommendations on safety and travel into our sources of advice.
We will confirm the new dates, venue and further details about the conference in the coming days.
We would also like to express our sincere gratitude to all CML patient advocates, doctors, service providers and volunteers who have helped us with the organisation and program planning for Horizons 2020 Costa Rica.
Our commitment now is to work hard to reschedule and prepare an excellent CML Horizons conference for which we intend to exceed the expectations of conference attendees as they continue to learn, share and grow all together.
Stay tuned and follow our social media channels for more information!
Coronavirus disease and CML patients
The novel Coronavirus and the COVID-19 Disease
Information for Chronic Phase Chronic Myeloid Leukemia Patients
State of the Art as of 08 March 2020
Dr Michael Deininger (USA), Dr François Guilhot (France), Dr Jeroen Janssen (Netherlands), Dr Tim Hughes (Australia), Dr Jeffrey Lipton (Canada), Dr Franck Nicolini (France),
Dr Jerry Radich (USA), Dr Delphine Rea (France), Dr Giuseppe Saglio (Italy), Dr Suzanne Saussele (Germany), Dr Rick Silver (USA), Dr Juan Luis Steegmann (Spain).
Introduction
SARS-Cov 2 is a novel coronavirus that belongs to the large Coronaviruses (CoV) family. It emerged in December 2019 in Wuhan, China. This new virus is responsible for an illness called COVID-19 ranging from a simple cold to a more severe respiratory infection. The virus is spreading across the globe, representing a pandemic alert.
Transmission
Conventional routes of transmission of the new coronavirus consist of contact with respiratory droplets from infected persons. People may also possibly be infected when touching a surface or object that has the live virus on it then touching their mouth, eyes or nose although it may not be the main route of infection since in general, survivability of coronaviruses on surfaces is considered as poor. Finally, the new coronavirus can be detected in the gastrointestinal tract, saliva and urine, so these routes of potential transmission are currently under investigation.
CML Advocates Network statement on Coronavirus Disease 2019 (COVID-19)
The CML Advocates Network is closely monitoring the information concerning the Coronavirus Disease 2019 (COVID-19) worldwide.
At the present time, all our activities including the CML Horizons Conference 2020 continue as planned.
In the event that the situation changes, we will immediately inform our members and the wider CML community of the new circumstances through our website and communication channels. For updates, please follow us on Twitter, Facebook or LinkedIn.
We are committed to guarantee the safety of our participants with all possible measures and are currently seeking CML-specific medical advice from CML medical experts.
Please, make sure you follow the recommendations provided by the World Health Organization (WHO) and your local authorities.
For further information about the CML Horizons Conference 2020 or any other CML Advocates Network activity, please contact us at info@cmladvocates.net